CH CRL (R4)
0.9.0 - Draft

This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions

CodeSystem: NKRS - DSSplus

Summary

Defining URL:http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-dssplus
Version:0.9.0
Name:NkrsDSSplus
Title:NKRS - DSSplus
Status:Active as of 2022-02-04 02:14:21+0100
Definition:

The DSSplus (Durie-Salmon Plus staging system) is the revised Durie-Salmon staging system for multiple myeloma classification, based on MRI findings, FDG PET/CT findings, or both.

DSSplus (Variable number: 4.30) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

Publisher:Bundesamt für Gesundheit BAG
Copyright:

CC-BY-SA-4.0

Content:Complete: All the concepts defined by the code system are included in the code system resource
Value Set:http://fhir.ch/ig/ch-crl/ValueSet/nkrs-dssplus ( is the value set for all codes in this code system)
Source Resource:XML / JSON / Turtle

This Code system is referenced in the content logical definition of the following value sets:

This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-dssplus defines the following codes:

CodeDisplayDefinition
IA Stage IASmoldering or indolent. Can have single plasmocytoma or limited disease at imaging; Normal renal function (serum creatinine level < 2.0 mg/dL).
IB Stage IB< 5 focal lesions, mild diffuse disease; Abnormal renal function (serum creatinine level ≥ 2.0 mg/dL).
IIA Stage IIA5–20 focal lesions; moderate diffuse disease; Normal renal function (serum creatinine level < 2.0 mg/dL).
IIB Stage IIB5–20 focal lesions; moderate diffuse disease; Abnormal renal function (serum creatinine level ≥ 2.0 mg/dL).
IIIA Stage IIIA> 20 focal lesions; moderate diffuse disease; normal renal function (serum creatinine level < 2.0 mg/dL).
IIIB Stage IIIB> 20 focal lesions; moderate diffuse disease; Abnormal renal function (serum creatinine level ≥ 2.0 mg/dL).